J. Day

Exosomal microRNA: a diagnostic marker for lung cancer.

Douglas D. Taylor, C. Gerçel-Taylor, G. Kloecker, 2008, Clinical lung cancer.

Clinical Aspects of Metabolomics

A. Lane, T. Fan, M. Bousamra, 2012 .

Phase II trial of second-line erlotinib and digoxin in patients with non-small cell lung cancer (NSCLC).

G. Kloecker, F. Kayali, D. Miller, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.